Recent News about Alta Partners

Edit
More about Alta Partners
Edit

Alta Partners | Life Science Venture Capital Home Strategy Portfolio Team News Contact LP Sign In Innovation and Expertise in Life Sciences Investing Alta Partners is a leading venture capital firm in life sciences, funding over 145 companies in the industry since 1996. Our diverse and integrated team brings together a powerful depth of knowledge and experience, delivering tangible results for our companies and our investors. Alta Partners News January 11, 2015The Global Healthcare Exits Report: OrbiMed and Alta Partners Figured Most Prominently in Venture's Best Exits December 25, 2014Alta Partners Figures Prominently Among 2014's Largest US-Based VC-Backed Healthcare Exits September 08, 2014Healthcare's Top Venture Capital Firms Portfolio News July 27, 2016Eyeing a potential market launch, Astellas orders up a $95M third course of Cytokinetics pipeline July 26, 2016Prolacta Bioscience Receives Social Impact Award From Association for Corporate Growth July 23, 2016SutroVax raises $22 million in Series A June 27, 2016AcelRx Pharmaceuticals Joins Russell 3000 and Russell 2000 Indexes June 20, 2016SCYNEXIS Announces Launch of Public Offering of Common Stock and Warrants February 22, 2016Trevena, Inc. Receives FDA Breakthrough Therapy Designation for Oliceridine Portfolio Highlights January 17, 20142013: Alta Partners Portfolio Highlights December 3, 2013CBinsights ranks Alta as one of the top three in value creation Allakos Carbylan Therapeutics, Inc. Kiadis Pharma See our complete portfolio ... © 19962016 Alta Partners